| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $13,890,733 ) (Continued on the next page) |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM111835 | Automation of the chemical synthesis of human milk oligosaccharides | 000 | 8 | NIH | 12/20/2021 | $277,357 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 002 | 6 | NIH | 2/14/2022 | $434,870 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 003 | 6 | NIH | 3/23/2022 | $1,152 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL139554 | Structural enzymology of protein C | 000 | 5 | NIH | 5/4/2022 | $539,815 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK120651 | ApoL1 and its kidney disease associated variants: ion permease activity, molecular structure, and podocyte injury. | 000 | 4 | NIH | 3/25/2022 | $372,760 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DA043811 | Pathways from Chronic Prescription Opioid Use to New Onset Mood Disorder | 000 | 4 | NIH | 1/21/2022 | $547,374 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DA043811 | Pathways from Chronic Prescription Opioid Use to New Onset Mood Disorder | 001 | 4 | NIH | 3/31/2022 | $60,821 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM130746 | Mechanisms of DNA hand-off during lesion repair in BER and NER | 000 | 5 | NIH | 1/17/2022 | $286,335 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01EY031008 | Iron and Diabetic Retinopathy | 000 | 3 | NIH | 2/3/2022 | $367,388 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Allosteric equilibria of thrombin and its precursors | 000 | 4 | NIH | 5/26/2022 | $378,750 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA242188 | Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity | 000 | 3 | NIH | 1/27/2022 | $365,697 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA242188 | Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity | 001 | 3 | NIH | 6/10/2022 | $32,507 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK125048 | The role of FSP27b on dietary lipid absorption, lipoprotein secretion, and oxidative metabolism | 000 | 3 | NIH | 1/19/2022 | $306,787 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK125048 | The role of FSP27b on dietary lipid absorption, lipoprotein secretion, and oxidative metabolism | 001 | 3 | NIH | 3/29/2022 | $34,088 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 3 | NIH | 1/20/2022 | $22,795 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 3 | NIH | 1/20/2022 | $319,143 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 3 | NIH | 4/1/2022 | $37,994 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA237149 | Metabolic Control of Innate and Adaptive Immunity in Breast Cancer | 000 | 3 | NIH | 1/6/2022 | $387,828 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA237149 | Metabolic Control of Innate and Adaptive Immunity in Breast Cancer | 001 | 3 | NIH | 6/8/2022 | $34,474 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS111120 | Novel therapeutic approaches for traumatic brain injury induced cognitive deficits | 000 | 3 | NIH | 12/27/2021 | $298,265 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 000 | 3 | NIH | 2/3/2022 | $349,774 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 001 | 3 | NIH | 6/13/2022 | $38,864 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AG064069 | Antisense Oligonucleotides for Targeting Nonsense-mediated mRNA Decay in Frontotemporal Dementia | 000 | 4 | NIH | 5/13/2022 | $378,750 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM133967 | Mechanisms of RPA, Recombinases, and Mediators in Homologous Recombination | 000 | 3 | NIH | 6/10/2022 | $159,866 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 000 | 3 | NIH | 11/23/2021 | $378,750 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK122401 | SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION | 000 | 3 | NIH | 4/12/2022 | $340,875 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 2 | NIH | 11/17/2021 | $656,876 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UH3HD096929 | ITEST: Innovative Tools to Expand Youth-Friendly HIV Self-Testing | 002 | 4 | NIH | 6/3/2022 | $237,209 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | D1930852 | Nursing Workforce Diversity | 00 | 6 | HRSA | 5/26/2022 | $546,823 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 00 | 7 | HRSA | 5/24/2022 | $650,000 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 00 | 7 | HRSA | 5/24/2022 | $100,000 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 00 | 7 | HRSA | 5/24/2022 | $187,500 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 000 | 1 | NIH | 3/9/2022 | $667,594 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15DK132727 | Insulin sensitivity in skeletal muscle | 000 | 1 | NIH | 3/7/2022 | $378,750 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23DA053433 | A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women | 000 | 1 | NIH | 2/28/2022 | $173,342 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23AR079035 | Neighborhood Barriers and Facilitators to Walking, the Epidemiology of Knee Osteoarthritis and Developing Effective Exercise Prescriptions | 000 | 1 | NIH | 4/1/2022 | $157,505 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 002 | 3 | NIH | 2/17/2022 | $151,855 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 003 | 3 | NIH | 2/18/2022 | $272,027 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 3 | NIH | 12/1/2021 | $587,832 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 000 | 1 | NIH | 2/24/2022 | $186,877 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI169487 | Role of intestinal microbiota in driving injury mechanisms in short bowel syndrome | 000 | 1 | NIH | 2/25/2022 | $214,010 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21HD107596 | Exploration of the role of CART/GPR160 in metabolism in the setting of Magel2 deficiency: Implications for Prader Willi Syndrome | 000 | 1 | NIH | 6/10/2022 | $227,250 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI171734 | Role of RNA-binding protein in immune evasion of Mtb in macrophages | 000 | 1 | NIH | 6/3/2022 | $189,375 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30NS124254 | TBI-induced adenosinergic dysregulation causes cognitive impairment and accelerates Alzheimer's disease pathology | 000 | 1 | NIH | 5/23/2022 | $35,036 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD032206 | Liquid chromatography and mass spectrometry instrument system | 000 | 1 | NIH | 5/25/2022 | $249,528 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | T32GM141602 | Pharmacological Sciences Training Grant | 000 | 1 | NIH | 5/23/2022 | $240,786 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | MC142100 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 00 | 2 | HRSA | 5/13/2022 | $459,478 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | T7635369 | Maternal and Child Health Public Health Training Program | 00 | 3 | HRSA | 4/4/2022 | $349,865 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structure and dynamics of prothrombin | 000 | 26 | NIH | 5/31/2022 | $378,750 |
|
